Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Androgenetic alopecia].

R Hoffman1

  • 1Universitts-Hautklinik Marburg, Marburg. rolf.hoffman@mailer.uni-marburg.de

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|March 5, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Environmental Toxins Found Historically in the Polycythemia Vera Cluster Area and their Potential for Inducing DNA Damage.

Journal of environmental & analytical toxicology·2021
Same author

A phase I study of panobinostat and ruxolitinib in patients with primary myelofibrosis (PMF) and post--polycythemia vera/essential thrombocythemia myelofibrosis (post--PV/ET MF).

Leukemia research·2019
Same author

Which positive factors give general practitioners job satisfaction and make general practice a rewarding career? A European multicentric qualitative research by the European general practice research network.

BMC family practice·2019
Same author

A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis.

Leukemia·2019
Same author

Does hydroxycarbamide therapy really induce leukemic transformation in patients with essential thrombocythemia?

Leukemia research·2018
Same author

Pan-Caspase Inhibitor Prevents Anti-CD3 Mediated T-Lymphocyte Proliferation.

TheScientificWorldJournal·2018
Same journal

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Viral infections of the skin].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Viral exanthems in children].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Erratum to: Digital health applications and data protection].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Virus-induced exanthems in returning travellers].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Venous ulcus cruris-Surgical treatment].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
See all related articles

Androgenetic alopecia, the most common hair loss, involves genetically sensitive follicles reacting to androgens. Recent research offers new insights into its causes, treatments, and practical applications for both men and women.

Area of Science:

  • Dermatology
  • Endocrinology

Context:

  • Androgenetic alopecia is a prevalent condition affecting both males and females.
  • Despite differing clinical presentations, the underlying pathogenetic mechanisms are shared.
  • Genetically predisposed hair follicles exhibit heightened sensitivity to androgens.

Purpose:

  • To provide a critical overview of recent advancements in androgenetic alopecia research.
  • To assess the practical relevance of new findings in pathophysiology, management, and therapy.

Summary:

  • The article reviews updated knowledge on the mechanisms driving androgenetic alopecia.
  • It critically evaluates novel therapeutic strategies and management approaches.
  • Focus is placed on the shared pathophysiology in men and women.

Related Experiment Videos

Impact:

  • Offers clinicians an updated perspective on treating hair loss.
  • Highlights the practical implications of recent scientific discoveries.
  • Aims to improve patient outcomes through evidence-based insights.